The FDA has approved the expanded use of Regeneron's drug Evkeeza in children to treat a rare disease that causes high cholesterol. 

Share:
More In Science
FDA Updates Ozempic Label
The Food and Drug Administration updated the labeling for Ozempic acknowledging reports of blocked intestines for those that use the medication.
Load More